IP Library Granted Patent US 11,187,660
Granted Patent B2
US 11,187,660 · App. 15/391,607 · Granted Nov 30, 2021

Fluorescent probes for monitoring voltage by photo-induced electron transfer

Inventors: Evan Walker Miller (La Jolla, CA); Roger Y. Tsien (La Jolla, CA)
Assignee: The Regents of the University of California
G01N21/6486C09K11/06G01N33/5008G01N33/542C09K2211/1007C09K2211/1011C09K2211/1088G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,187,660
App. No.
15/391,607
Granted
Nov 30, 2021
Kind
B2
Abstract

Compounds and methods for determining transmembrane potential, monitoring changes in transmembrane potential, and/or drug screening are provided. In one aspect, compounds of the invention have a structure according to the formula: E-M-A, wherein A is a fluorophore, selected from xanthenes, coumarins, cyanines, bimanes, and difuloroboradizaindacenes, charged at physiological pH; M is a molecular wire; and E is a hydrophobic moiety, wherein A and E are capable of being involved in a photo-induced, intramolecular electron transfer that quenches the fluorescence of A in response to a voltage condition. When in use, compounds of the invention are membrane-impermeant and oriented within the cell membrane such that the charged moiety localizes at the outer leaflet of the lipid bilayer and the hydrophobic moiety and molecular wire associate with the hydrophobic portion of the lipid bilayer. The rate of electron transfer, fluorescence intensity, and quenching are altered in response to changes in transmembrane potential.

Claims (5)

1. A kit comprising a buffer and a compound, wherein the compound has a structure selected from:

2. The kit of claim 1 , wherein the compound is substituted with a targeting moiety.

3. The kit of claim 2 , wherein the targeting moiety is selected from a nucleic acid, a peptide, a saccharide, a lipid, and a combination thereof.

4. The kit of claim 3 , wherein the targeting moiety is specific to an excitable cell.

5. The kit of claim 4 , wherein the excitable cell is selected from a neuron, a nerve cell, an endocrine secretory cell, a neuroendocrine secretory cell, a cardiac muscle cell, a smooth muscle cell, and a skeletal muscle cell.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 28, 2017
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043367/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2017
From: TSIEN, ROGER; MILLER, EVAN WALKER
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 043081/0831 →
Continuity (3)
Continuation 14118836
Provisional Application 61488075 · May 19, 2011
Related Publication 20170315059A1 · Nov 2, 2017